RecruitingNail PsoriasisNail DamageMycosis
Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up
Sponsor: Wooshin Labottach Co., Ltd.
You may qualify if…
- ✓ aged 18 years or older Fragility Nails Distal Subungual Onychomycosis Nail Psoriasis affecting ≤75% of the nail bed according to a photographic documentation and to a subjective evaluation by the Investigator.
You may not qualify if…
- ✕ Patients that have proximal subungual onychomycosis, if their distal subungual onychomycosis is extended into the proximal portion of the nail or if it affects \>75% of the nail.
- ✕ Patients with conditions known to cause abnormal nail appearance, immunosuppression and signs of severe peripheral circulatory insufficiency
- ✕ Patients who had used topical antifungal, anti-psoriasis nail treatment within one month or systemic antifungal treatment within three months.
- ✕ Patients who have participated in another clinical nail study during the previous three months
- ✕ Patients who have a known allergy to any of the study treatments.
- ✕ Patients with unrelated nail disorders: onychomycosis, nail psoriasis, genetically induced onychodystrophy.
- ✕ Patients with other nail disorders, active or severe psoriasis elsewhere, other autoimmune or inflammatory diseases.
Source: ClinicalTrials.gov · NCT07029516 · last updated 2026-01-26